News Archives - Page 490 of 722

TuesdayOct 06, 2020 2:24 pm

The Movie Studio Inc. (MVES) Leveraging Social Media Branding and Influencer Engagement to Promote New App

MVES engaged services of Digital Talent Studio Inc., social media mogul Brian Breach of Sikey Corp. to promote The Movie Studio App The Movie Studio App leverages both advertiser-based and subscription models Social media models, influencers expected to promote app to hundreds of thousands of followers MVES’s two key verticals include open architecture for original content plus an over-the-top platform that pulls additional content through revenue sharing agreements In a bold move to boost the promotion of The Movie Studio App, The Movie Studio Inc. (OTC: MVES), a vertically integrated motion picture production and distribution company, has engaged Digital Talent…

TuesdayOct 06, 2020 2:02 pm

Net Element Inc. (NASDAQ: NETE), Mullen Technologies Announce Facility Build-Out, Pre-Sales of Fully Electric EV

Mullen Technologies begins built-out of pilot facility, accepting orders for MX-05 SUV. Facility slated for April 2021 completion; first MX-05 SUVs rolling off production line by Q2 2022. In August, Net Element, Mullen Technologies announced execution of definitive agreement to merge. The announcement by Mullen Technologies Inc. that it has begun to build out its pilot manufacturing facility and take pre-orders for its M05 fully electric SUV bodes well for Net Element (NASDAQ: NETE). Earlier this year, Net Element, a global financial technology and value-added solutions group, and Mullen Technologies announced a merger agreement—so good news for Mullen means good…

TuesdayOct 06, 2020 12:51 pm

Processa Pharmaceuticals Inc. (NASDAQ: PCSA) is “One to Watch”

Processa Pharmaceuticals aims to develop products where existing clinical evidence of efficacy already exists in the targeted unmet medical need condition with the drug itself or a drug with very similar pharmacology The Processa process focuses on the advancement of drugs that are ready for clinical development or have minimal pre-IND enabling studies to complete Processa’s current development pipeline features multiple clinical drug candidates, given the recent acquisitions of three additional development-focused licensing agreement since June 2020 In total, the company’s combined scientific, development and regulatory experience has resulted in more than 30 drug approvals by the U.S. Food and…

MondayOct 05, 2020 1:44 pm

InsuraGuest Technologies, Inc. (TSX.V: ISGI) (OTC: IGSTF) Partners with Hub International to Expand Hospitality Liability Coverage

The partnership will help InsuraGuest’s coverage potentially reach more than 9,300 hospitality customers in the United States and Canada by the middle of 2021 Hospitality Liability coverage allows covered properties to transfer certain liabilities, lowering claim ratio and risk profiles InsuraGuest’s product can also help properties generate revenue by keeping a percent of the nightly software fee Innovative insurtech leader InsuraGuest Technologies (TSX.V: ISGI) (OTC: IGSTF) has sealed a premier preferred partnership with leading global insurance brokerage Hub International Limited (“HUB”), to provide InsuraGuest’s Hospitality Liability coverage to properties in Hub International’s portfolio. Signed via wholly owned subsidiary InsuraGuest, the…

MondayOct 05, 2020 12:51 pm

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Partnership with Imaging Specialists IAG Gives Tech Boost to Upcoming Brain Cancer Drug Trials

Clinical-stage biotech developer CNS Pharmaceuticals is working to demonstrate the potential effectiveness of its novel drug, Berubicin, in treating aggressive and rare brain cancer glioblastoma multiforme (“GBM”) CNS expects to launch Phase II trials of Berubicin later this year or in Q1 of 2021, building on promising results shown in initial trials One patient in the Phase I trial has remained cancer-free over the course of 14 years, and 44 percent of the patients who could be evaluated experienced a clinically significant positive response to Berubicin CNS’s laser-focused strategy for developing a GBM therapy is also leading the company to…

MondayOct 05, 2020 12:27 pm

Revenue Growth Amid Pandemic Helps Trxade Group, Inc. (NASDAQ: MEDS) Build its Transparency in Pharmaceuticals Strategy

Pharmaceutical services innovator Trxade Group Inc. has gained investor attention as it has emerged as a responsive healthcare market force during the ongoing COVID-19 pandemic As the pandemic began to unfold earlier this year, Trxade Group saw revenues jump effectively to three times their previous Q1 level, largely as a result of personal protective equipment products The company’s core mission has been to help small, community-centered retail pharmacies compete with large national chains through prescription drug price transparency and AI-driven protocols that help pharmacies stay abreast of what’s available Trxade Group’s advances in delivering services ranging from consultation to drug…

MondayOct 05, 2020 11:33 am

Sugarmade (SGMD) 8K Filing Notes Status, Potential of Upcoming LA-Based Cannabis-Delivery Locations

SGMD has filed updated Form 8K Current Report with SEC Filing includes information about issues related to company’s status, including planned expansion of BudCars cannabis-delivery service Sugarmade sees “major business opportunities out of both sites once operations begin” Sugarmade (OTCQB: SGMD), a product and branding marketing company investing in operations and technologies with disruptive potential, has released the publication of a Form 8K Current Report filing with the United States Securities and Exchange Commission (“SEC”) (https://ibn.fm/Ngrsg). The filing includes specific information about several issues related to the company’s performance and outlook, including planned expansion of the BudCars cannabis delivery service.…

MondayOct 05, 2020 10:56 am

Rritual Mushrooms Inc. is “One to Watch”

Rritual’s suite of premium functional mushroom and adaptogenic elixirs is designed to offer various health benefits, such as increased immunity, cognitive function, stress management and more The company’s products are expected to be available online through Rritual’s site and Amazon by fall 2020 The Rritual team has extensive ties and influential relationships with leading retail businesses, providing a wide market for growth The functional mushroom industry has no clear and dominant leader, allowing Rritual to target this role with its premium products. Rritual is currently the only premium brand on the market The global functional mushroom market is expected to…

FridayOct 02, 2020 12:12 pm

Pure Extract Technologies Inc. Ideally Positioned to Become Leader in Rapidly Growing Mushroom Space

Research shows psilocybin produces immediate, substantial and sustained improvements in anxiety and depression Global medicinal mushroom market projected to increase by almost $14 billion annually for the next several years Pure Extracts is a plant-based extraction company with new vertical in the mushroom space Recent groundbreaking research indicates that psilocybin-assisted psychotherapy may be effective in treating depression, a debilitating disorder that plagues an estimated 300 million people in the United State. Psilocybin is the main psychoactive ingredient in “magic” mushrooms. With growing interest in the mushroom sector — both psychedelic and functional — companies such as Pure Extract Technologies could see exciting…

ThursdayOct 01, 2020 3:16 pm

Trxade Group, Inc. (NASDAQ: MEDS) Ending Q3 Strong with Increased Investor Exposure

The company’s current independent pharmacy member base represents over 50% of the United States pharmaceutical market within that vertical Actively used in all 50 states with over 11,700 pharmacies in its network, serving around 15 million patients indirectly through these networks of pharmacies Pharmaceutical supplies and services provider Trxade Group (NASDAQ: MEDS) benefited from an increased exposure to potential investors in September, by attending several virtual investor events and conferences, where it was given the opportunity to present its innovative platform and its advantages for pharmacy members. The company started the last month of the third fiscal quarter strong by…

Site Search

Company Search

Category: News